- Tetraxim® (DTaP-IPV) is a 4-in-1 booster vaccine and the only inactivated poliomyelitis containing combination vaccine in India that has full-dose antigenic strength of Diphtheria, Tetanus and acellular Pertussis (whooping cough) for preschoolers.
MUMBAI, INDIA – Sanofi Pasteur India, the vaccines global business unit of Sanofi announced the launch of Tetraxim® (DTaP-IPV). The booster vaccine is indicated for preschoolers and provides protection against four major diseases – Diphtheria, Pertussis, Tetanus and Polio. Tetraxim® combines four vaccines into one, thus reducing the number of injections, increasing comfort and improving vaccination compliance for children and reducing parental anxiety.
As immunity against Diphtheria, Tetanus, and Pertussis wanes over time, it is important to ensure necessary protection by being up to date with booster vaccinations. A vaccine containing full-dose antigens stimulates adequate immune response with better tolerability. This ensures preschoolers receive the right vaccine with the appropriate antigen content at the right time and have sustained protection against disease.
With Tetraxim®, Sanofi Pasteur currently protects school children in more than 100 countries, with 63 million doses distributed worldwide.
Annapurna Das, COUNTRY HEAD, INDIA, Sanofi Pasteur said, “Booster vaccines are designed to boost the immunity acquired during prior vaccination. It works as a reminder for a child’s immune system and can also stop the spread of infection to their siblings and grandparents, making it important to maintain vaccination schedules of preschoolers.”
The Indian Academy of Pediatrics, an association of Indian pediatricians, recommends full-dose DTaP for preschoolers.
Right Vaccine, Right Time
Delaying or missing vaccinations means children are unprotected for longer than they need to be, often at the time when they are most at risk of illness and serious complications from diseases. The timing of vaccine doses is carefully chosen based on years of research to help protect children at the right time. To ensure complete protection, children should follow the vaccination schedule and ensure that the appropriate dose vaccine is administered.
About Sanofi India
As Sanofi India, we are in a great place to make a difference. For six decades, we have earned the trust of our customers and stakeholders, for our commitment to promoting health in India. As partners of hope in every Indian’s health journey, we engage across the entire health cycle – from prevention with vaccines to wellness, treatment, patient support & capacity building.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Media Relations Contact
Senior Director – Communications & CSR, India
Head, Vaccines and Internal Communication
Read more from the Health Issues India press office here.